MedTrace Logo

A Study of Lower Dose Radiation Therapy for People With Prostate Cancer

NCT07635238 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2026-06-18

No results posted yet for this study

Summary

The purpose of this study is to see whether giving a lower (de-escalated) dose of radiation therapy to some parts of the prostate can reduce side effects compared to giving the same (uniform) dose of radiation therapy to the whole prostate.

Conditions

Interventions

RADIATION

MR-guided Stereotactic Body Radiation Therapy

MR-guided 2 fraction Stereotactic Body Radiation Therapy

Sponsors & Collaborators

Principal Investigators

  • Victoria Brennan, MBBCH BAO · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-28
Primary Completion
2030-05-28
Completion
2030-05-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07635238 on ClinicalTrials.gov